
The global market for Large Volume Wearable Syringe was valued at US$ 254 million in the year 2024 and is projected to reach a revised size of US$ 440 million by 2031, growing at a CAGR of 8.2% during the forecast period.
A large-volume wearable syringe is an innovative drug delivery device, usually divided into two types: mechanical and electronic. It can be attached to the human body and deliver precise doses comfortably and unobtrusively over a fixed or variable period of time. This syringe not only reduces the patient's pain and improves the convenience of drug delivery, but also allows patients to manage drug injections at home, reducing the risk of hospital-acquired infections, and is an important advancement in modern medical technology.
North American market for Large Volume Wearable Syringe is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Large Volume Wearable Syringe is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Large Volume Wearable Syringe include Eitan Medical, Stevanato Group, RAUMEDIC, Sonceboz, BD, Sorrel Medical Ltd, Europlaz Technologies, LTS LOHMANN Therapie-Systeme AG, Insulet Corporation, Tandem Diabetes Care, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Large Volume Wearable Syringe, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Large Volume Wearable Syringe.
The Large Volume Wearable Syringe market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Large Volume Wearable Syringe market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Large Volume Wearable Syringe manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Eitan Medical
Stevanato Group
RAUMEDIC
Sonceboz
BD
Sorrel Medical Ltd
Europlaz Technologies
LTS LOHMANN Therapie-Systeme AG
Insulet Corporation
Tandem Diabetes Care
Enable Injections
Roche
Segment by Type
Electronic Syringe
Mechanical Syringe
Segment by Application
Hospital
Clinic
Household
Others
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Large Volume Wearable Syringe manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Large Volume Wearable Syringe in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Large Volume Wearable Syringe Market Overview
1.1 Product Definition
1.2 Large Volume Wearable Syringe by Type
1.2.1 Global Large Volume Wearable Syringe Market Value Comparison by Type (2024 VS 2031)
1.2.2 Electronic Syringe
1.2.3 Mechanical Syringe
1.3 Large Volume Wearable Syringe by Application
1.3.1 Global Large Volume Wearable Syringe Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Household
1.3.5 Others
1.4 Global Large Volume Wearable Syringe Market Size Estimates and Forecasts
1.4.1 Global Large Volume Wearable Syringe Revenue 2020-2031
1.4.2 Global Large Volume Wearable Syringe Sales 2020-2031
1.4.3 Global Large Volume Wearable Syringe Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Large Volume Wearable Syringe Market Competition by Manufacturers
2.1 Global Large Volume Wearable Syringe Sales Market Share by Manufacturers (2020-2025)
2.2 Global Large Volume Wearable Syringe Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Large Volume Wearable Syringe Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Large Volume Wearable Syringe, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Large Volume Wearable Syringe, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Large Volume Wearable Syringe, Product Type & Application
2.7 Global Key Manufacturers of Large Volume Wearable Syringe, Date of Enter into This Industry
2.8 Global Large Volume Wearable Syringe Market Competitive Situation and Trends
2.8.1 Global Large Volume Wearable Syringe Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Large Volume Wearable Syringe Players Market Share by Revenue
2.8.3 Global Large Volume Wearable Syringe Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Large Volume Wearable Syringe Market Scenario by Region
3.1 Global Large Volume Wearable Syringe Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Large Volume Wearable Syringe Sales by Region: 2020-2031
3.2.1 Global Large Volume Wearable Syringe Sales by Region: 2020-2025
3.2.2 Global Large Volume Wearable Syringe Sales by Region: 2026-2031
3.3 Global Large Volume Wearable Syringe Revenue by Region: 2020-2031
3.3.1 Global Large Volume Wearable Syringe Revenue by Region: 2020-2025
3.3.2 Global Large Volume Wearable Syringe Revenue by Region: 2026-2031
3.4 North America Large Volume Wearable Syringe Market Facts & Figures by Country
3.4.1 North America Large Volume Wearable Syringe Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Large Volume Wearable Syringe Sales by Country (2020-2031)
3.4.3 North America Large Volume Wearable Syringe Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Large Volume Wearable Syringe Market Facts & Figures by Country
3.5.1 Europe Large Volume Wearable Syringe Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Large Volume Wearable Syringe Sales by Country (2020-2031)
3.5.3 Europe Large Volume Wearable Syringe Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Large Volume Wearable Syringe Market Facts & Figures by Region
3.6.1 Asia Pacific Large Volume Wearable Syringe Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Large Volume Wearable Syringe Sales by Region (2020-2031)
3.6.3 Asia Pacific Large Volume Wearable Syringe Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Large Volume Wearable Syringe Market Facts & Figures by Country
3.7.1 Latin America Large Volume Wearable Syringe Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Large Volume Wearable Syringe Sales by Country (2020-2031)
3.7.3 Latin America Large Volume Wearable Syringe Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Large Volume Wearable Syringe Market Facts & Figures by Country
3.8.1 Middle East and Africa Large Volume Wearable Syringe Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Large Volume Wearable Syringe Sales by Country (2020-2031)
3.8.3 Middle East and Africa Large Volume Wearable Syringe Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Large Volume Wearable Syringe Sales by Type (2020-2031)
4.1.1 Global Large Volume Wearable Syringe Sales by Type (2020-2025)
4.1.2 Global Large Volume Wearable Syringe Sales by Type (2026-2031)
4.1.3 Global Large Volume Wearable Syringe Sales Market Share by Type (2020-2031)
4.2 Global Large Volume Wearable Syringe Revenue by Type (2020-2031)
4.2.1 Global Large Volume Wearable Syringe Revenue by Type (2020-2025)
4.2.2 Global Large Volume Wearable Syringe Revenue by Type (2026-2031)
4.2.3 Global Large Volume Wearable Syringe Revenue Market Share by Type (2020-2031)
4.3 Global Large Volume Wearable Syringe Price by Type (2020-2031)
5 Segment by Application
5.1 Global Large Volume Wearable Syringe Sales by Application (2020-2031)
5.1.1 Global Large Volume Wearable Syringe Sales by Application (2020-2025)
5.1.2 Global Large Volume Wearable Syringe Sales by Application (2026-2031)
5.1.3 Global Large Volume Wearable Syringe Sales Market Share by Application (2020-2031)
5.2 Global Large Volume Wearable Syringe Revenue by Application (2020-2031)
5.2.1 Global Large Volume Wearable Syringe Revenue by Application (2020-2025)
5.2.2 Global Large Volume Wearable Syringe Revenue by Application (2026-2031)
5.2.3 Global Large Volume Wearable Syringe Revenue Market Share by Application (2020-2031)
5.3 Global Large Volume Wearable Syringe Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Eitan Medical
6.1.1 Eitan Medical Company Information
6.1.2 Eitan Medical Description and Business Overview
6.1.3 Eitan Medical Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Eitan Medical Large Volume Wearable Syringe Product Portfolio
6.1.5 Eitan Medical Recent Developments/Updates
6.2 Stevanato Group
6.2.1 Stevanato Group Company Information
6.2.2 Stevanato Group Description and Business Overview
6.2.3 Stevanato Group Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Stevanato Group Large Volume Wearable Syringe Product Portfolio
6.2.5 Stevanato Group Recent Developments/Updates
6.3 RAUMEDIC
6.3.1 RAUMEDIC Company Information
6.3.2 RAUMEDIC Description and Business Overview
6.3.3 RAUMEDIC Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.3.4 RAUMEDIC Large Volume Wearable Syringe Product Portfolio
6.3.5 RAUMEDIC Recent Developments/Updates
6.4 Sonceboz
6.4.1 Sonceboz Company Information
6.4.2 Sonceboz Description and Business Overview
6.4.3 Sonceboz Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Sonceboz Large Volume Wearable Syringe Product Portfolio
6.4.5 Sonceboz Recent Developments/Updates
6.5 BD
6.5.1 BD Company Information
6.5.2 BD Description and Business Overview
6.5.3 BD Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.5.4 BD Large Volume Wearable Syringe Product Portfolio
6.5.5 BD Recent Developments/Updates
6.6 Sorrel Medical Ltd
6.6.1 Sorrel Medical Ltd Company Information
6.6.2 Sorrel Medical Ltd Description and Business Overview
6.6.3 Sorrel Medical Ltd Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sorrel Medical Ltd Large Volume Wearable Syringe Product Portfolio
6.6.5 Sorrel Medical Ltd Recent Developments/Updates
6.7 Europlaz Technologies
6.7.1 Europlaz Technologies Company Information
6.7.2 Europlaz Technologies Description and Business Overview
6.7.3 Europlaz Technologies Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Europlaz Technologies Large Volume Wearable Syringe Product Portfolio
6.7.5 Europlaz Technologies Recent Developments/Updates
6.8 LTS LOHMANN Therapie-Systeme AG
6.8.1 LTS LOHMANN Therapie-Systeme AG Company Information
6.8.2 LTS LOHMANN Therapie-Systeme AG Description and Business Overview
6.8.3 LTS LOHMANN Therapie-Systeme AG Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.8.4 LTS LOHMANN Therapie-Systeme AG Large Volume Wearable Syringe Product Portfolio
6.8.5 LTS LOHMANN Therapie-Systeme AG Recent Developments/Updates
6.9 Insulet Corporation
6.9.1 Insulet Corporation Company Information
6.9.2 Insulet Corporation Description and Business Overview
6.9.3 Insulet Corporation Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Insulet Corporation Large Volume Wearable Syringe Product Portfolio
6.9.5 Insulet Corporation Recent Developments/Updates
6.10 Tandem Diabetes Care
6.10.1 Tandem Diabetes Care Company Information
6.10.2 Tandem Diabetes Care Description and Business Overview
6.10.3 Tandem Diabetes Care Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Tandem Diabetes Care Large Volume Wearable Syringe Product Portfolio
6.10.5 Tandem Diabetes Care Recent Developments/Updates
6.11 Enable Injections
6.11.1 Enable Injections Company Information
6.11.2 Enable Injections Description and Business Overview
6.11.3 Enable Injections Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Enable Injections Large Volume Wearable Syringe Product Portfolio
6.11.5 Enable Injections Recent Developments/Updates
6.12 Roche
6.12.1 Roche Company Information
6.12.2 Roche Description and Business Overview
6.12.3 Roche Large Volume Wearable Syringe Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Roche Large Volume Wearable Syringe Product Portfolio
6.12.5 Roche Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Large Volume Wearable Syringe Industry Chain Analysis
7.2 Large Volume Wearable Syringe Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Large Volume Wearable Syringe Production Mode & Process Analysis
7.4 Large Volume Wearable Syringe Sales and Marketing
7.4.1 Large Volume Wearable Syringe Sales Channels
7.4.2 Large Volume Wearable Syringe Distributors
7.5 Large Volume Wearable Syringe Customer Analysis
8 Large Volume Wearable Syringe Market Dynamics
8.1 Large Volume Wearable Syringe Industry Trends
8.2 Large Volume Wearable Syringe Market Drivers
8.3 Large Volume Wearable Syringe Market Challenges
8.4 Large Volume Wearable Syringe Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Eitan Medical
Stevanato Group
RAUMEDIC
Sonceboz
BD
Sorrel Medical Ltd
Europlaz Technologies
LTS LOHMANN Therapie-Systeme AG
Insulet Corporation
Tandem Diabetes Care
Enable Injections
Roche
Ìý
Ìý
*If Applicable.
